Showing 1-8 of 8 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Impact of Inflammatory Cytokines on ER-Mitochondria Crosstalk and Proinsulin Folding in Beta Cells | East Tennessee State University | Anoop Arunagiri | Cures | 01-August-2025 to 31-July-2027 | $241.431,00 |
| Investigation of AKS-107 immunotherapeutic in mice and human cells | Vanderbilt University Medical Center (VUMC) | Rachel Bonami | Cures | 01-July-2024 to 30-June-2027 | $800.000,00 |
| Bcl6 and the B/Tfh axis in type 1 diabetes pathogenesis | Vanderbilt University Medical Center (VUMC) | Dudley McNitt | Cures | 01-March-2024 to 28-February-2027 | $265.320,00 |
| Development of Allosteric G6PC1 Partial Inhibitors | Vanderbilt University | Richard O'Brien | Improving Lives | 01-October-2023 to 08-August-2026 | $549.940,00 |
| Targeting the Opposing Roles of Prostaglandin E2 Receptors, EP3 and EP4, in the Pathogenesis of Type One Diabetes | Vanderbilt University Medical Center (VUMC) | Maureen Gannon | Cures | 01-October-2023 to 30-September-2025 | $200.000,00 |
| Targeting the Autoimmune Germinal Center Axis in Type 1 Diabetes | Vanderbilt University Medical Center (VUMC) | Rachel Bonami | Cures | 01-September-2023 to 31-August-2025 | $600.000,00 |
| Determination of autoreactive B lymphocyte development by ROS in T1D | Vanderbilt University Medical Center (VUMC) | Christopher Wilson | Cures | 01-July-2023 to 30-June-2026 | $234.766,00 |
| Determination of Iatrogenic Hyperinsulinemia’s Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes | Vanderbilt University Medical Center (VUMC) | Justin Gregory | Improving Lives | 01-March-2020 to 30-June-2025 | $749.999,80 |